Teva Pharmaceutical Industries Ltd ADR buy UBS Group AG
Start price
11.07.24
/
50%
€15.70
Target price
11.07.25
€22.04
Performance (%)
3.82%
Price
12.09.24
€16.30
Summary
This prediction is currently active. With a performance of 3.82%, the BUY prediction by UBS_Group_AG for Teva Pharmaceutical Industries Ltd ADR is trending in the right direction. This prediction currently runs until 11.07.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Teva Pharmaceutical Industries Ltd ADR | -1.807% | -1.807% |
iShares Core DAX® | -0.168% | 4.802% |
iShares Nasdaq 100 | 2.946% | 3.520% |
iShares Nikkei 225® | 1.319% | 6.746% |
iShares S&P 500 | 2.044% | 3.551% |
Comments by UBS_Group_AG for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at UBS Group AG from $22.00 to $24.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by UBS_Group_AG for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€16.90
03.09.24
03.09.24
€23.55
03.09.25
03.09.25
-3.55%
12.09.24
12.09.24
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€8.94
27.11.23
27.11.23
€11.87
27.11.24
27.11.24
82.33%
12.09.24
12.09.24